Home » FDA Greenlights Nevro Leads
FDA Greenlights Nevro Leads
The FDA has approved Nevro’s new surgical leads, which are intended for use with Senza Spinal Cord Stimulation, a neuromodulation platform delivering HF10 therapy.
The SCS therapy system delivers electrical pulses via a compact battery-powered generator implanted under the skin located near the spinal cord to treat chronic leg and back pain. — Joya Patel
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May